Topics

Articles

States continue to push for a ‘bio-economic’ foundation

Workforce and Supply Chain Top Location Must-Have Lists for Biopharma

Drugmakers recalibrate anti-counterfeiting and serialization efforts

Even While Regulatory Mandates Slip Into the Future, Brand Protection Needs Remain

Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment

A Pitched Battle in Cardiovascular Drug Marketing

Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services

Security